Beneficial ownership — 13D / 13G
85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| BlackRock Inc. | G Genpact LTD | 13G/A | 10.1% | Jan 31, 2024 | 2y |
| BlackRock Inc. | ACET Adicet Bio, Inc. | 13G/A | 3% | Jan 31, 2024 | 2y |
| BlackRock Inc. | APLD Applied Digital Corp. | 13G/A | 4.6% | Jan 31, 2024 | 2y |
| BlackRock Inc. | LQDA Liquidia Corp | 13G/A | 4.97% | Jan 31, 2024 | 2y |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | HHLA HH&L Acquisition Co. | 13G/A | 0% | Jan 31, 2024 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 41.7% | Jan 31, 2024 | 2y |
| BlackRock Inc. | CWBC Community West Bancshares | 13G | 4.9% | Jan 31, 2024 | 2y |
| BlackRock Inc. | BCLO BlackRock ETF Trust II | 13G/A | 85.8% | Jan 31, 2024 | 2y |
| BlackRock Inc. | FNKO Funko, Inc. | 13G/A | 4.9% | Jan 31, 2024 | 2y |
| BlackRock Inc. | BKF iShares, Inc. | 13G/A | 0.6% | Jan 31, 2024 | 2y |
| BlackRock Inc. | BCLO BlackRock ETF Trust II | 13G/A | 4% | Jan 31, 2024 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 21.6% | Jan 31, 2024 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G | 10.8% | Jan 31, 2024 | 2y |
| BlackRock Inc. | ORIC Oric Pharmaceuticals, Inc. | 13G/A | 4.5% | Jan 31, 2024 | 2y |
| BlackRock Inc. | BKF iShares, Inc. | 13G/A | 6.6% | Jan 31, 2024 | 2y |
| BlackRock Inc. | CODI Compass Diversified Holdings | 13G/A | 4.98% | Jan 31, 2024 | 2y |
| BlackRock Inc. | UONE Urban One, Inc. | 13G/A | 4.9% | Jan 31, 2024 | 2y |
| Orin Hirschman | CGTX Cognition Therapeutics Inc | 13G/A | 4.8% | Jan 30, 2024 | 2y |
| Orin Hirschman | SMTK SmartKem, Inc. | 13G/A | 9.9% | Jan 29, 2024 | 2y |
| Carlyle Group Inc. | ACET Adicet Bio, Inc. | 13D/A | 4.1% | Jan 25, 2024 | 2y |
| Orin Hirschman | ELUT Elutia Inc. | 13G/A | 9.9% | Jan 25, 2024 | 2y |
| Rick Nechio | AMZE Amaze Holdings, Inc. | 13D/A | 9.85% | Jan 25, 2024 | 2y |
| Orin Hirschman | CLRB Cellectar Biosciences, Inc. | 13G/A | 8.7% | Jan 23, 2024 | 2y |
| ATHOS KG | IMTX Immatics N.V. | 13G/A | 4.8% | Jan 22, 2024 | 2y |
| Orin Hirschman | MYO Myomo, Inc. | 13G/A | 9.9% | Jan 16, 2024 | 2y |
| Jonathan B. Rubini | GMVD G Medical Innovations Holdings Ltd. Ordinary Shares | 13D/A | 5.96% | Jan 15, 2024 | 2y |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | SLDB Solid Biosciences Inc. | 13G | 7.25% | Jan 8, 2024 | 2y |
| Endeavor Foundation, Inc. | CET Central Securities Corp | 13G/A | 33.2% | Dec 31, 2023 | 2y |
| PZENA INVESTMENT MANAGEMENT LLC | NWL Newell Brands Inc. | 13G | 13.2% | Dec 31, 2023 | 2y |
| APG Asset Management US Inc. | COLD Americold Realty Trust | 13G/A | 6% | Dec 31, 2023 | 2y |
| BML Investment Partners, L.P. | ORKA Oruka Therapeutics, Inc. | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | LCAA L Catterton Asia Acquisition Corp Class A Ordinary Shares | 13G/A | 0% | Dec 31, 2023 | 2y |
| Hawkins, Inc. Employee Stock Ownership Plan and Trust (Tax ID: ) Hawkins, Inc. Employee Stock Ownership Plan for Certain Collectively Bargained Employees and Trust (Tax ID: ) | HWKN Hawkins Inc | 13G/A | 5% | Dec 31, 2023 | 2y |
| Saba Capital Management, L.P. | ADIS Aedis Energy Inc. | 13G/A | 1.11% | Dec 31, 2023 | 2y |
| Michael C. Brilley | LARK Landmark Bancorp Inc | 13G/A | 5.7% | Dec 31, 2023 | 2y |
| Linden Advisors LP | MCAF Mountain Crest Acquisition Corp. IV Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| APG Asset Management US Inc. | JKHY Jack Henry & Associates Inc | 13G/A | 5.5% | Dec 31, 2023 | 2y |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | SKGR SK Growth Opportunities Corporation Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Saba Capital Management, L.P. | CMCAF Piermont Valley Acquisition Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| LRA Ventures, LLC | ENFN Enfusion, Inc. | 13G/A | 8.46% | Dec 31, 2023 | 2y |
| Orin Hirschman | THTX Theratechnologies Inc. Common | 13G/A | 8.1% | Dec 31, 2023 | 2y |
| Saba Capital Management, L.P. | EVGR Evergreen Corporation Class A Ordinary Share | 13G/A | 5.14% | Dec 31, 2023 | 2y |
| DAVENPORT & Co LLC | MCRI Monarch Casino & Resort Inc | 13G | 6.23% | Dec 31, 2023 | 2y |
| EPS Ventures Ltd | CLCO Cool Company Ltd. | 13G | 58.2% | Dec 31, 2023 | 2y |
| Fen Ye | LXEH Lixiang Education Holding Co. Ltd. | 13G/A | 40.7% | Dec 31, 2023 | 2y |
| Fosun International Ltd | JG Aurora Mobile Ltd | 13G/A | 9.2% | Dec 31, 2023 | 2y |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | BTAIQ BioXcel Therapeutics, Inc. | 13G/A | 1.55% | Dec 31, 2023 | 2y |
| BML Investment Partners, L.P. | CLYM Climb Bio, Inc. | 13G/A | 8.5% | Dec 31, 2023 | 2y |
| Linden Advisors LP | XAGE Longevity Health Holdings, Inc. | 13G/A | 1.6% | Dec 31, 2023 | 2y |
| Yifan Li | HSAI Hesai Group | 13G | 7.6% | Dec 31, 2023 | 2y |